Drug test for the qualitative detection of cells expressing the CD3 and/or CD4 antigens - Vietnam Registration 2402938ĐKLH/BYT-HTTB
Access comprehensive regulatory information for Drug test for the qualitative detection of cells expressing the CD3 and/or CD4 antigens in Vietnam's medical device market through Pure Global AI's free database. This Risk Class TTBYT Loại C medical device is registered under number 2402938ĐKLH/BYT-HTTB and manufactured by Immunotech SAS. The authorized representative in Vietnam is CÔNG TY TNHH KỸ THUẬT NAM PHƯƠNG.
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 300,000+ Vietnamese medical device registrations, helping global MedTech companies navigate Vietnam MOH regulations, identify competitors, and discover partnership opportunities efficiently.
Device Details
Registration Details
2402938ĐKLH/BYT-HTTB
000.00.04.G18-231130-0021
CD3-FITC CD4-PE
A07733
Technical Details
The CD3-FITC CD4-PE antibody cocktail, which combines fluorescent dye, enables the qualitative and quantitative determination of cells expressing the CD3 and/or CD4 antigens in human biological samples using flow cytometry.
Dates and Status
Oct 22, 2024

